Other Research

Population Control – The Kenyan Perspective

The first birth control clinic was opened in Nairobi, the Kenyan Capital, 44 years ago. The second one opened a year later in 1956 at the Port Town of Mombasa. These two amalgamated into the Family a Planning Association of Kenya (FPAK). In 1963, FPAK

Read More »

The Progesterone/HIV Link

3 July 1996 FDA Deputy CommissionerDr. Lester CrawfordFood & Drug Administration200 C Street, SWWashington, DC  20204 Dear Dr. Crawford, This is to draw you attention to additional information about the possible link between Norplant’s progesterone-based approach to contraception and an increased risk of contracting HIV.

Read More »

Norplant Petition Press Release

Population Group Demands Halt of Norplant Sales; Cites Health Risks to Women and Targeting of Minority Populations EMBARGOED FOR RELEASE:Press Contact: (540) 622-5240June 27, 1996 WASHINGTON, DC — The Population Research Institute (PRI) today filed a formal petition with the U.S. Food and Drug Administration

Read More »

How You Can Help

Send your letters to the Food and Drug Administration. The Administration will consider the request and take public comments on the issue. We know that the FDA takes these comments into account and so we ask everyone interested in removing Norplant from the market to

Read More »

Norplant: Personal Testimonies

Norplant alleged to Cause Blindness: Abuse of Women in Bangladesh and Haiti Documented by PRI Staff PRI ReviewMay/June 1996 When the U.S. Food and Drug Administration approved Norplant in December 1990, this Population Council product was hailed as a boon to women around the world.

Read More »

The Progesterone/HIV Link

3 July 1996 FDA Deputy CommissionerDr. Lester CrawfordFood & Drug Administration200 C Street, SWWashington, DC  20204 Dear Dr. Crawford, This is to draw you attention

Read More »

Norplant Petition Press Release

Population Group Demands Halt of Norplant Sales; Cites Health Risks to Women and Targeting of Minority Populations EMBARGOED FOR RELEASE:Press Contact: (540) 622-5240June 27, 1996

Read More »

How You Can Help

Send your letters to the Food and Drug Administration. The Administration will consider the request and take public comments on the issue. We know that

Read More »